Edgewise Therapeutics Inc (EWTX) Ownership

$29.51

$0.64 (-2.12%)
Last update: 11:28 PM EST
Day's range
$29.33
Day's range
$30.7

Edgewise Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 6.63 M $164.54 M   4.39% 6.29%
VANGUARD GROUP INC 01/29/2026 4.87 M $120.89 B   1.41% 4.62%
SIREN, L.L.C. 02/13/2026 4.53 M $112.41 M   16.24% 4.29%
MORGAN STANLEY 02/13/2026 2.91 M $72.23 M   234.71% 2.76%
UBS GROUP AG 01/29/2026 2.12 M $52.54 M   1,755.00% 2.01%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.75 M $43.34 B   1.66% 1.66%
STATE STREET CORP 02/13/2026 1.72 M $42.62 M   1.03% 1.63%
BIOIMPACT CAPITAL LLC 02/17/2026 1.66 M $41.08 M   -3.81% 1.57%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.47 M $36.60 B   359.25% 1.40%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.21 M $30.11 M   2.58% 1.15%
AMERICAN CENTURY COMPANIES INC 02/13/2026 1.19 M $29.44 M   8.31% 1.12%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/12/2026 910.00 K $22.58 M   100.00% 0.86%
ABRDN PLC 01/16/2026 821.94 K $20.40 M   32.60% 0.78%
NORGES BANK 02/10/2026 751.36 K $18.64 M   100.00% 0.71%
VICTORY CAPITAL MANAGEMENT INC 02/13/2026 746.56 K $18.53 M   49.72% 0.71%
GOLDMAN SACHS GROUP INC 02/10/2026 718.37 K $17.83 B   36.10% 0.68%
MARSHALL WACE, LLP 02/13/2026 681.92 K $16.93 M   100.00% 0.65%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 02/13/2026 640.40 K $15.89 M   100.00% 0.61%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 611.38 K $15.17 M   2.31% 0.58%
EVENTIDE ASSET MANAGEMENT, LLC 02/13/2026 568.31 K $14.10 M   0.00% 0.54%
CANDRIAM S.C.A. 02/13/2026 501.21 K $12.44 M   126.63% 0.48%
SOFINNOVA INVESTMENTS, INC. 02/13/2026 437.82 K $10.86 M   -15.84% 0.42%
PARKMAN HEALTHCARE PARTNERS LLC 02/17/2026 427.69 K $10.61 M   -22.26% 0.41%
BARCLAYS PLC 02/13/2026 372.74 K $9.25 M   58.85% 0.35%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 01/28/2026 271.39 K $6.73 M   104.81% 0.26%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 241.51 K $5.99 M   -3.64% 0.23%
CITIGROUP INC 02/13/2026 223.29 K $5.54 M   -58.53% 0.21%
DEUTSCHE BANK AG\ 02/11/2026 214.77 K $5.33 M   38.65% 0.20%
BANK OF NEW YORK MELLON CORP 02/10/2026 198.61 K $4.93 M   -2.76% 0.19%
NUVEEN, LLC 02/12/2026 169.47 K $4.21 M   -1.88% 0.16%
DAFNA CAPITAL MANAGEMENT LLC 02/17/2026 159.74 K $3.96 M   -25.26% 0.15%
JPMORGAN CHASE & CO 02/11/2026 146.04 K $3.62 M   112.51% 0.14%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/13/2026 145.29 K $3.57 M   -3.82% 0.14%
NEUBERGER BERMAN GROUP LLC 02/13/2026 127.14 K $3.15 M   -42.12% 0.12%
MILLENNIUM MANAGEMENT LLC 02/17/2026 126.44 K $3.14 M   -82.57% 0.12%
CITADEL ADVISORS LLC 02/17/2026 123.10 K $3.05 B   451.58% 0.12%
QUANTUM PRIVATE WEALTH, LLC 02/06/2026 106.02 K $2.63 M   0.14% 0.10%
SWISS NATIONAL BANK 02/12/2026 103.90 K $2.58 M   1.96% 0.10%
EXOME ASSET MANAGEMENT LLC 02/13/2026 100.05 K $2.48 M   -42.32% 0.09%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 98.06 K $2.43 M   -29.51% 0.09%
NEW YORK STATE COMMON RETIREMENT FUND 02/12/2026 88.94 K $2.21 M   6.59% 0.08%
SG AMERICAS SECURITIES, LLC 01/09/2026 88.72 K $2.20 M   797.92% 0.08%
ALPS ADVISORS INC 02/12/2026 86.93 K $2.16 M   70.08% 0.08%
RHUMBLINE ADVISERS 02/13/2026 85.08 K $2.11 B   -18.84% 0.08%
FEDERATED HERMES, INC. 02/12/2026 82.10 K $2.04 M   38.54% 0.08%
DEKABANK DEUTSCHE GIROZENTRALE 01/28/2026 80.00 K $1.56 M   0.00% 0.08%
JUMP FINANCIAL, LLC 02/17/2026 79.92 K $1.98 M   -1.13% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 78.20 K $1.94 M   2.22% 0.07%
WELLS FARGO & COMPANY/MN 02/13/2026 75.44 K $1.87 M   78.79% 0.07%
CITADEL ADVISORS LLC 02/17/2026 73.50 K $1.82 B   59.44% 0.07%

Edgewise Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 161 institutional investors and hedge funds held shares of Edgewise Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 6.63 M

VANGUARD GROUP INC: 4.87 M

Siren, L.L.C.: 4.53 M

MORGAN STANLEY: 2.91 M

UBS Group AG: 2.12 M

GEODE CAPITAL MANAGEMENT, LLC: 1.75 M

32.91% of Edgewise Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 46.98 M shares in the last 24 months. This purchase volume represents approximately $1.39 B in transactions.